HEPLISAV-B® 2024 net product revenue grew 26% year-over-year to $268 million; net product revenue expected to be $305 to $325 million in 2025 Top-line results in ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

We expect investors to focus on the sales performance of ADMA Biologics’ ADMA portfolio of marketed products and other ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2024. "Gilead delivered another exceptionally ...

With several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue that new direct-acting antiviral drugs, and new NUCs in particular ...

A recent study from Temple University finds a majority of Pennsylvania college students consider themselves educated about ...

Investors' focus will likely be on GILD's HIV franchise performance and oncology sales when the company reports ...

We list the best Gantt chart software, to make it simple and easy to better visualize and manage progress when dealing with larges projects. Gantt chart software can be a powerful weapon in a ...

Saudi Cement 9M 2024 profit rises to SAR 301.3M; Q3 at SAR 100.2M 9 M 2024 Saudi Cement H1 2024 profit falls 4% to SAR 201.1M; Q2 at SAR 87.3M 6 M 2024 Saudi Cement profit down 8% to SAR 113.8M in Q1 ...

We list the best free Gantt chart software, to make it simple and easy to follow the progress of project management schedules, without a paid-for subscription. A Gantt chart is a very important ...

but one hepatitis C study, which recruited homeless individuals from shelters, special projects and medical centres in Oxford, found 26.5% of individuals positive using oral fluid testing.25 Our ...